Reorganization of the Office of Financial Resources, 56753 [2024-15099]

Agencies

• Centers for Disease Control and Prevention
• DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 89, Number 132 (Wednesday, July 10, 2024)]
[Notices]
[Page 56753]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-15099]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Reorganization of the Office of Financial Resources

AGENCY: Centers for Disease Control and Prevention (CDC), the 
Department of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: CDC has modified its structure. This notice announces the 
reorganization of the Office of Financial Resources (OFR) and the CDC 
Immediate Office of the Director (IOD). OFR added a branch and a new 
office was established within the CDC IOD.

DATES: This reorganization was approved by the Director of CDC on June 
20, 2024, and became effective.

FOR FURTHER INFORMATION CONTACT: Victoria Hunter, Centers for Disease 
Control and Prevention, 1600 Clifton Road NE, MS H21-12, Atlanta, GA 
30329. Telephone 404-639-7124; Email: [email protected].

SUPPLEMENTARY INFORMATION: Part C (Centers for Disease Control and 
Prevention) of the Statement of Organization, Functions, and 
Delegations of Authority of the Department of Health and Human Services 
(45 FR 67772-76, dated October 14, 1980, and corrected at 45 FR 69296, 
October 20, 1980, as amended most recently at 89 FR 19832, dated March 
20, 2024) is amended to reflect the reorganization of Office of 
Financial Resources and the CDC Immediate Office of the Director, 
Centers for Disease Control and Prevention. Specifically, the changes 
are as follows:
    I. Under Part C, Section C-B, Organization and Functions, make the 
following changes:

 Abolish the Office of Appropriations (CAJE14)
 Establish the Budget Formulation Branch (CAJEVR)
 Establish the Office of Budget Policy and Appropriations (CAR)

    II. Under Part C, Section C-B, Organization and Functions, after 
the Budget Execution Services Branch 4 (CAJEVQ) insert the following:
    Budget Formulation Branch (CAJEVR). (1) manages and coordinates 
development of the budget for CDC and ATSDR from submissions prepared 
by Center//Institute/Office contacts; (2) formulates the CDC and ATSDR 
financial plan, and evaluates and assures total budget requests conform 
to current administration policy and economic assumptions in 
coordination with CIOs; (3) coordinates with the Office of Planning, 
Performance, and Evaluation to include the Government Performance and 
Results Act (GPRA) Modernization Act performance measures with budget 
proposals to HHS, OMB and Congress; (4) prepares periodic summary 
analysis and impact statements on budget allowances and applicable 
congressional actions; (5) develops analyses of proposed budget 
estimates and supporting narrative through the use of available 
financial data reporting systems for senior CDC management; (6) 
maintains liaison with HHS, OMB, the Government Accountability Office, 
and other government organizations on CDC's financial management 
matters; (7) collaborates with other parts of CDC in the development 
and implementation of long-range program and financing plans; (8) 
completes requirements in timing and reporting of cleared information 
to parties outside the Executive Branch (i.e., Congress, media, 
public); and (9) develops and presents analyses, special reports, 
background exhibits, and graphical material on budget proposals, budget 
activities, and related matters.
    After the Office of Policy, Performance, and Evaluation (CAQ) 
insert the following: Office of Budget Policy and Appropriations (CAR). 
The Office of Budget Policy and Appropriations: (1) provides 
leadership, consultation, guidance, and advice on matters of public 
health and budget policy; (2) leads all Centers for Disease Control and 
Prevention (CDC) and Agency for Toxic Substances and Disease Registry 
(ATSDR) Congressional appropriations leadership activities including 
strategic outreach and interaction with Congressional appropriators on 
appropriations/budget matters; (3) supports the Office of Financial 
Resources in the development of CDC's and ATSDR's annual funding 
request in accordance with Department of Health and Human Services 
(HHS), Office of Management and Budget (OMB), and Congressional 
requirements, policies, procedures, and regulations; (4) maintains 
liaison with the HHS Office of the Secretary (OS), OMB, other 
government organizations, and Congress on appropriations and budget 
policy matters; (5) develops materials for, and participates in, budget 
policy and financial reviews and hearings before HHS, OMB, and 
Congress; (6) collaborates with CDC Washington Office (CDC/W) and other 
parts of CDC, and outside stakeholders, in the development and 
implementation of agency-wide legislative strategy; (7) advances the 
CDC policy agenda through interactions with appropriations leadership; 
(8) coordinates with Centers/Institute/Offices on Congressional 
appropriations leadership strategy and interactions, ensuring a unified 
presentation of CDC interests to legislators; (9) leads the development 
and updates to spend plans for CDC supplemental funding, infectious 
diseases rapid response reserve fund requests, and new budget programs; 
(10) tracks, analyzes, and reports on appropriations legislation; (11) 
protects and advances the agency's reputation, scientific credibility, 
and interests; (12) informs CDC leadership of current developments and 
provides insight into the budget policy environment; and (13) 
coordinates, with the CDC/W and CIO partnership activities that relate 
to budget policy and appropriations to advance the agency's priorities.

Delegations of Authority

    All delegations and redelegations of authority made to officials 
and employees of affected organizational components will continue in 
them or their successors pending further redelegation, provided they 
are consistent with this reorganization.

(Authority: 44 U.S.C. 3101)

Robin D. Bailey, Jr.,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-15099 Filed 7-9-24; 8:45 am]
BILLING CODE 4163-18-P